LPPL
MRNA icon

Loftus Peak Pty Ltd’s Moderna MRNA Stock Holding History

Loftus Peak Pty Ltd’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-255,836
Closed -$17.9M – 27
2026
Q2 		$17.9M Buy
+255,836
New +$13.2M 2.44% 18

Other funds holding MRNA

Douglas Lane & Associates
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
BVL
Beau Ventures, LLc Pittsford, New York $1.06B AUM 83.06% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
LAI
Legal Advantage Investments Los Altos Hills, California $468M AUM 7.83% 1-Year Est. Return
PFM
Patton Fund Management Dallas, Texas $389M AUM 65.14% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
GAA
Green Alpha Advisors Niwot, Colorado $148M AUM 98.22% 1-Year Est. Return
GCA
Gallagher Capital Advisors Argyle, Texas $187M AUM 21.63% 1-Year Est. Return
NIM
Nicollet Investment Management Minneapolis, Minnesota $336M AUM 22.24% 1-Year Est. Return
BSCCG
Blue Sky Capital Consultants Group Poway, California $239M AUM 14.34% 1-Year Est. Return

Loftus Peak Pty Ltd's MRNA Position: Q3 2026 in Review

Loftus Peak Pty Ltd sold out of Moderna (MRNA) in Q3 2026, closing a stake of 255,836 shares — an estimated $17.9M sold.

Loftus Peak Pty Ltd first reported a position in MRNA in Q2 2026 and held it in 1 quarter. The position peaked at $17.9M in Q2 2026. 92 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • Loftus Peak Pty Ltd reported no remaining Moderna position as of Q3 2026 after selling out during the quarter.
  • Loftus Peak Pty Ltd sold 255,836 Moderna shares in Q3 2026, an estimated $17.9M.
  • Loftus Peak Pty Ltd first reported a position in Moderna in Q2 2026 and held it in 1 quarter.
  • Loftus Peak Pty Ltd's Moderna position peaked at $17.9M in Q2 2026.
  • 92 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on Loftus Peak Pty Ltd's 13F filing for Q3 2026, filed 15 Oct 2026.